from Great Game India:
According to a study if you received one dose of the Johnson & Johnson COVID vaccine, you are 3.5 times more likely to develop blood clots compared to the unvaccinated general population. Researchers found that 8.5 J&J recipients developed the clots for every 100,000 persons, compared to only 2.5 out of the general population. Researchers found that women between aged 30 and 64 were most at risk of developing the clotting.
TRUTH LIVES on at https://sgtreport.tv/
Earlier, German scientists found the exact 2 step process how the COVID-19 vaccine causes blood clots in recipients. They describe a series of events that has to happen in the body before the vaccines create these large clots.
German scientists have found out how the broken parts of Johnson & Johnson and AstraZeneca COVID-19 vaccines branded as Covishield in India mutate to trigger blood clots in recipients.
Scientists say the vaccine is sent into the cell nucleus instead of surrounding fluid, where parts of it break off and create mutated versions of themselves. The mutated versions then enter the body and trigger the blood clots.
Now, researchers from the Mayo Clinic in Rochester, Minnesota, compared data from the general population before the pandemic to data gathered from reported vaccine side-effects suffered by Americans.
They found that a person who received the vaccine was 3.5 times as likely to develop brain blood clots as an average person before the pandemic.
Blood clotting, and specifically cerebral venous sinus thrombosis (CVST) is a well known side-effect of the J&J vaccine, and the discovery of this risk was the reason usage of the vaccine was paused in April.
The US CDC and FDA lifted their recommended pause on use of Johnson & Johnson’s coronavirus vaccine with a condition that it will now include a safety label warning that its vaccine comes with blood clot risks.
The US Food and Drug Administration has also warned that Johnson & Johnson’s single-dose Covid-19 vaccine can cause Guillain-Barre syndrome, a rare disorder where the immune system attacks the nervous system and can result in paralysis.
Researchers, who published their findings in JAMA Internal Medicine on Monday, gathered data from Olmstead, County, Minnesota – a county of around 158,000 people 90 miles southeast of Minneapolis – from 2001 to 2015.
They then used the Centers for Disease Control and Prevention’s Vaccine Adverse Event Reporting System (VAERS) to find diagnoses of blood clots in people who received the J&J vaccine between the jab’s approval date at the end of February 2021 to May 7.
During the 14-year period, there were 39 Olmstead residents who developed CVST – a rare, potentially deadly, blood clotting condition that can form in a person’s brain.
Of that group, 29 had a risk factor within the 92 days proceeding development of the blood clot, such as infection, active cancer, or oral contraceptives for women.